Kevin Feeley - 09 Mar 2024 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Role: CHIEF FINANCIAL OFFICER
Signature: /s/ Devin Schaffer, Attorney-in-Fact
Issuer symbol: WGS
Transactions as of: 09 Mar 2024
Net transactions value: $0
Form type: 4
Filing time: 12 Mar 2024, 17:27:35 UTC
Previous filing: 05 Mar 2024
Next filing: 13 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	WGS	Class A Common Stock	Options Exercise	$0	+2,462	+10%	$0.000000	25,914	09 Mar 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	WGS	Restricted Stock Unit	Options Exercise	$0	-2,462	-8.3%	$0.000000	27,083	09 Mar 2024	Class A Common Stock	2,462		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
F2	6.25% vest in quarterly installments over the 4-year period commencing on March 9, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.